Skip to main content
TipRanks
Go Ultimate75% OFF

Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis

3 Followers
IN:YATHARTH

Yatharth Hospital and Trauma Care Services Limited

(NSE:YATHARTH)

Select Model
Rating:77Outperform
Price Target:INR 1,165.00â–²(9.78% Upside)
Action:reiterated
Date:09/18/26

Strong financial performance, led by revenue growth and a low-debt balance sheet, combined with bullish technical momentum are the main positive drivers; high valuation metrics weigh on the score.

Positive Factors
Strong Revenue GrowthRevenue growth of about 22% in the latest annual year, following solid prior growth, indicates the hospital network is continuing to scale. A growing revenue base can support broader clinical capacity and operating leverage, helping sustain the company’s competitive position over the next several quarters.
Negative Factors
Negative Free Cash FlowPersistent negative free cash flow means reported profit is not yet translating into internally available cash after investment and working-capital needs. This can constrain near-term financial flexibility, increase reliance on external funding, and make continued hospital expansion more capital intensive.

Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)

-40%-20%0%20%40%60%IN:YATHARTH+36.48%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 102.22B
Dividend Yield
0.05%
Average Volume (3M)
33.48K
Price to Earnings (P/E)
53.9
Beta (1Y)
1.27
Revenue Growth
50.40%
EPS Growth
24.94%
Country
India
Employees
7,440
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model

Company Description

Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare se...

Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview

Summary

Strong revenue growth and significantly strengthened balance sheet with low leverage, offset by negative free cash flow and margin pressures.

Income Statement

82Very Positive

Balance Sheet

92Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue14.86B12.07B8.80B6.71B5.20B4.01B
Gross Profit8.03B6.50B5.39B5.37B4.27B3.20B
EBITDA3.63B2.92B2.36B1.96B1.37B1.13B
Net Income1.91B1.75B1.31B1.14B657.68M441.62M
Balance Sheet
Total Assets25.91B22.82B17.31B10.19B4.86B4.26B
Cash, Cash Equivalents and Short-Term Investments2.91B2.98B5.15B2.39B382.36M120.31M
Total Debt4.68B2.64B115.86M846.47M2.67B2.64B
Total Liabilities6.92B4.74B940.45M1.45B3.03B3.09B
Stockholders Equity18.76B17.81B16.05B8.74B1.83B1.17B
Cash Flow
Free Cash Flow0-956.83M-1.61B-964.43M439.70M468.01M
Operating Cash Flow02.21B1.50B-30.78M637.84M599.35M
Investing Cash Flow0-6.17B-4.20B-2.26B-203.10M-521.75M
Financing Cash Flow02.56B5.19B3.04B-177.48M-11.24M

Yatharth Hospital and Trauma Care Services Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price1061.20

Price Trends

50DMA1013.33Positive
100DMA936.67Positive
200DMA832.53Positive

Market Momentum

MACD14.99Negative
RSI62.57Neutral
STOCH86.92Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 1061.20 is above the 20-day moving average (MA) of 981.31, above the 50-day MA of 1013.33, and above the 200-day MA of 832.53, indicating a bullish trend. The MACD of 14.99 indicates Negative momentum. The RSI at 62.57 is Neutral, neither overbought nor oversold. The STOCH value of 86.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.

Yatharth Hospital and Trauma Care Services Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:YATHARTH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:YATHARTHIN:YATHARTH77OutperformINR 102.25B53.92―0.05%50.40%24.94%
IN:ARTEMISMEDIN:ARTEMISMED73OutperformINR 50.86B43.66―0.14%14.77%8.40%
IN:NHIN:NH67NeutralINR 380.62B44.24―0.24%71.40%1.76%
IN:FORTISIN:FORTIS64NeutralINR 577.54B55.52―0.13%17.50%2.40%
IN:MAXHEALTHIN:MAXHEALTH63NeutralINR 919.79B66.79―0.21%15.17%1.63%
IN:APOLLOHOSPIN:APOLLOHOSP62NeutralINR 1.22T54.67―0.23%19.24%34.11%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%0%20%40%IN:YATHARTHIN:APOLLOHOSPIN:ARTEMISMEDIN:FORTISIN:MAXHEALTHIN:NHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:YATHARTH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:YATHARTHYatharth Hospital and Trauma Care Services Limited1061.20266.5233.54%
IN:APOLLOHOSPApollo Hospitals Enterprise Limited8515.501045.7314.00%
IN:ARTEMISMEDArtemis Medicare Services Ltd.321.2550.4118.61%
IN:FORTISFortis Healthcare Ltd.765.00-178.15-18.89%
IN:MAXHEALTHMax Healthcare Institute Ltd945.00-174.91-15.62%
IN:NHNarayana Hrudayalaya Ltd.1862.50-160.90-7.95%

Yatharth Hospital and Trauma Care Services Limited Corporate Events

Yatharth Hospital boosts authorised capital and secures major minority investment

Sep 17, 2026

Yatharth Hospital & Trauma Care Services Limited’s board has approved an increase in authorised share capital from INR 115 crore to INR 150 crore, subject to shareholder and regulatory approvals, requiring an amendment to its Memorandum of Associatio...

Yatharth Hospital Challenges Large Tax Demands After Final Assessments

Sep 14, 2026

Yatharth Hospital and its subsidiaries AKS Medical & Research Centre and Ramraja Multispeciality Hospital have received final income tax assessment orders from the Delhi tax authorities, raising aggregate demands of over Rs. 43 crores in tax and abou...

Yatharth Hospital Files FY 2025-26 Business Responsibility and Sustainability Report

Sep 3, 2026

Yatharth Hospital and Trauma Care Services Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 to the National Stock Exchange of India and BSE Limited in compliance with SEBI disclosure regulatio...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 18, 2026